Marex discloses 5.2% Upexi ownership stake

Marex Securities Products Inc. and its parent Marex Group plc have disclosed a beneficial ownership position in Upexi, Inc. common stock.

Rhea-AI Filing Summary

Marex Securities Products Inc. and its parent Marex Group plc have disclosed a beneficial ownership position in Upexi, Inc. common stock. The filing reports beneficial ownership of 3,297,966 shares of Upexi common stock, representing 5.2% of the outstanding class. Both entities report sole voting and sole dispositive power over these shares, with no shared voting or shared dispositive power.

The securities are Upexi common stock with a par value of $0.001 per share. The reporting persons certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Upexi, and are not part of any control-related transaction other than activities solely in connection with a nomination under the applicable proxy rule.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake in Upexi (UPXI) did Marex report in this Schedule 13G?

Marex Securities Products Inc. and Marex Group plc reported beneficial ownership of 3,297,966 shares of Upexi common stock, representing 5.2% of the class.

Which entities are the reporting persons in this Upexi (UPXI) Schedule 13G?

The reporting persons are Marex Securities Products Inc., organized in Delaware, and its parent Marex Group plc, organized in the United Kingdom.

What voting and dispositive powers over Upexi (UPXI) shares do the Marex entities report?

Each reporting person lists sole voting power over 3,297,966 shares and sole dispositive power over the same 3,297,966 shares, with no shared voting or dispositive power.

Does the Marex Upexi (UPXI) Schedule 13G indicate an intent to influence control of the company?

The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of Upexi and are not held in connection with any such transaction, other than activities solely in connection with a nomination under § 240.14a-11.

What class of Upexi (UPXI) securities is covered in this Schedule 13G?

The filing relates to Upexi Common Stock with a par value of $0.001 per share, identified by CUSIP 39959A205.

Who signed the Marex Schedule 13G related to Upexi (UPXI)?

The statement was signed by Jennifer Kaiser, COO, and Scott Linsley, Corporate Secretary, each dated 01/08/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/08/2026 - 10:19 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

UPEXI, INC.

(Name of Issuer)

Common Stock, par value $0.001

(Title of Class of Securities)

39959A205

(CUSIP Number)

01/05/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 39959A205

1

Names of Reporting Persons

Marex Securities Products Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,297,966.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,297,966.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,297,966.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.2 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. 39959A205

1

Names of Reporting Persons

Marex Group plc

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,297,966.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,297,966.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,297,966.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.2 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: UPEXI, INC.
(b)	Address of issuer's principal executive offices: 3030 ROCKY POINT DRIVE, SUITE 420, TAMPA, FLORIDA, 33607
Item 2.
(a)	Name of person filing: Marex Securities Products, Inc. Marex Group plc
(b)	Address or principal business office or, if none, residence: Marex Securities Products, Inc. 140 East 45th Street, Floor 10 & 11 New York, NY 10017 Marex Group plc 155 Bishopsgate London, X0 EC2M 3TQ
(c)	Citizenship: Marex Securities Products, Inc. Delaware, USA Marex Group plc United Kingdom
(d)	Title of class of securities: Common Stock, par value $0.001
(e)	CUSIP No.: 39959A205
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3297966
(b)	Percent of class: 5.2 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3297966
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3297966
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Marex Securities Products Inc.

Signature:	Jennifer Kaiser
Name/Title:	COO
Date:	01/08/2026

Marex Group plc

Signature:	Scott Linsley
Name/Title:	Corporate Secretary
Date:	01/08/2026